Literature DB >> 33239759

A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor.

Wen Sun1,2,3, Li-Nan Chen4, Qingtong Zhou5,6, Li-Hua Zhao1, Dehua Yang1,2, Huibing Zhang4, Zhaotong Cong7, Dan-Dan Shen4, Fenghui Zhao7, Fulai Zhou1,2, Xiaoqing Cai1,2, Yan Chen7, Yan Zhou1,2, Sarina Gadgaard8, Wijnand J C van der Velden8, Suwen Zhao5,9, Yi Jiang1, Mette M Rosenkilde8, H Eric Xu10,11, Yan Zhang12,13,14,15, Ming-Wei Wang16,17,18,19,20,21.   

Abstract

Glucagon-like peptides (GLP-1 and GLP-2) are two proglucagon-derived intestinal hormones that mediate distinct physiological functions through two related receptors (GLP-1R and GLP-2R) which are important drug targets for metabolic disorders and Crohn's disease, respectively. Despite great progress in GLP-1R structure determination, our understanding on the differences of peptide binding and signal transduction between these two receptors remains elusive. Here we report the electron microscopy structure of the human GLP-2R in complex with GLP-2 and a Gs heterotrimer. To accommodate GLP-2 rather than GLP-1, GLP-2R fine-tunes the conformations of the extracellular parts of transmembrane helices (TMs) 1, 5, 7 and extracellular loop 1 (ECL1). In contrast to GLP-1, the N-terminal histidine of GLP-2 penetrates into the receptor core with a unique orientation. The middle region of GLP-2 engages with TM1 and TM7 more extensively than with ECL2, and the GLP-2 C-terminus closely attaches to ECL1, which is the most protruded among 9 class B G protein-coupled receptors (GPCRs). Functional studies revealed that the above three segments of GLP-2 are essential for GLP-2 recognition and receptor activation, especially the middle region. These results provide new insights into the molecular basis of ligand specificity in class B GPCRs and may facilitate the development of more specific therapeutics.

Entities:  

Year:  2020        PMID: 33239759      PMCID: PMC7785020          DOI: 10.1038/s41422-020-00442-0

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  53 in total

Review 1.  Current and potential therapeutic targets of glucagon-like peptide-2.

Authors:  Kaori Austin; Melanie A Markovic; Patricia L Brubaker
Journal:  Curr Opin Pharmacol       Date:  2016-08-28       Impact factor: 5.547

2.  Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV.

Authors:  D J Drucker; Q Shi; A Crivici; M Sumner-Smith; W Tavares; M Hill; L DeForest; S Cooper; P L Brubaker
Journal:  Nat Biotechnol       Date:  1997-07       Impact factor: 54.908

3.  Pharmacological evidence for the relationship between the NMDA receptor and nitric oxide pathway and the antidepressant-like effects of glucagon-like peptide-2 in the mouse forced-swim test.

Authors:  Sachie Sasaki-Hamada; Yuya Nakamura; Kenichi Koizumi; Rena Nabeta; Jun-Ichiro Oka
Journal:  Behav Brain Res       Date:  2019-02-16       Impact factor: 3.332

4.  Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2.

Authors:  Sachie Sasaki-Hamada; Kaori Ito; Jun-Ichiro Oka
Journal:  Life Sci       Date:  2013-11-26       Impact factor: 5.037

5.  Effects of centrally administered glucagon-like peptide-2 on blood pressure and barosensitive neurons in spontaneously hypertensive rats.

Authors:  Sachie Sasaki-Hamada; Koji Narusawa; Ryuji Nakamura; Hitoshi Ishibashi; Jun-Ichiro Oka
Journal:  Neuropeptides       Date:  2018-04-18       Impact factor: 3.286

6.  Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

Authors:  D J Drucker; P Erlich; S L Asa; P L Brubaker
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

7.  Immunohistochemical determination of the site of hypotensive effects of glucagon-like peptide-2 in the rat brain.

Authors:  S Sasaki-Hamada; S Okada; K Ito; T Iwai; J-I Oka
Journal:  Neuroscience       Date:  2012-04-16       Impact factor: 3.590

Review 8.  Influence of glucagon-like peptide 2 on energy homeostasis.

Authors:  Sara Baldassano; Antonella Amato; Flavia Mulè
Journal:  Peptides       Date:  2016-09-21       Impact factor: 3.750

Review 9.  Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.

Authors:  Daniel J Drucker; Bernardo Yusta
Journal:  Annu Rev Physiol       Date:  2013-10-25       Impact factor: 19.318

Review 10.  GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity.

Authors:  Antonella Amato; Sara Baldassano; Flavia Mulè
Journal:  J Endocrinol       Date:  2016-04-05       Impact factor: 4.286

View more
  12 in total

1.  Assessing sequence-based protein-protein interaction predictors for use in therapeutic peptide engineering.

Authors:  François Charih; Kyle K Biggar; James R Green
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

2.  A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2.

Authors:  Yingna Xu; Wenbo Feng; Qingtong Zhou; Anyi Liang; Jie Li; Antao Dai; Fenghui Zhao; Jiahui Yan; Chuan-Wei Chen; Hao Li; Li-Hua Zhao; Tian Xia; Yi Jiang; H Eric Xu; Dehua Yang; Ming-Wei Wang
Journal:  Nat Commun       Date:  2022-04-27       Impact factor: 17.694

Review 3.  G protein-coupled receptors: structure- and function-based drug discovery.

Authors:  Dehua Yang; Qingtong Zhou; Viktorija Labroska; Shanshan Qin; Sanaz Darbalaei; Yiran Wu; Elita Yuliantie; Linshan Xie; Houchao Tao; Jianjun Cheng; Qing Liu; Suwen Zhao; Wenqing Shui; Yi Jiang; Ming-Wei Wang
Journal:  Signal Transduct Target Ther       Date:  2021-01-08

4.  Constitutive signal bias mediated by the human GHRHR splice variant 1.

Authors:  Zhaotong Cong; Fulai Zhou; Chao Zhang; Xinyu Zou; Huibing Zhang; Yuzhe Wang; Qingtong Zhou; Xiaoqing Cai; Qiaofeng Liu; Jie Li; Lijun Shao; Chunyou Mao; Xi Wang; Jihong Wu; Tian Xia; Li-Hua Zhao; Hualiang Jiang; Yan Zhang; H Eric Xu; Xi Cheng; Dehua Yang; Ming-Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-05       Impact factor: 11.205

5.  Modulating effects of RAMPs on signaling profiles of the glucagon receptor family.

Authors:  Lijun Shao; Yan Chen; Shikai Zhang; Zhihui Zhang; Yongbing Cao; Dehua Yang; Ming-Wei Wang
Journal:  Acta Pharm Sin B       Date:  2021-08-04       Impact factor: 11.413

Review 6.  An updated overview of glucagon-like peptide-2 analog trophic therapy for short bowel syndrome in adults.

Authors:  Changzhen Zhu; Yuanxin Li
Journal:  J Int Med Res       Date:  2022-03       Impact factor: 1.671

7.  Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors.

Authors:  Fenghui Zhao; Qingtong Zhou; Zhaotong Cong; Kaini Hang; Xinyu Zou; Chao Zhang; Yan Chen; Antao Dai; Anyi Liang; Qianqian Ming; Mu Wang; Li-Nan Chen; Peiyu Xu; Rulve Chang; Wenbo Feng; Tian Xia; Yan Zhang; Beili Wu; Dehua Yang; Lihua Zhao; H Eric Xu; Ming-Wei Wang
Journal:  Nat Commun       Date:  2022-02-25       Impact factor: 14.919

8.  Novel agonist and antagonist radioligands for the GLP-2 receptor. Useful tools for studies of basic GLP-2 receptor pharmacology.

Authors:  Sarina Gadgaard; Wijnand J C van der Velden; Sine P Schiellerup; Jenna Elizabeth Hunt; Maria B N Gabe; Johanne Agerlin Windeløv; Geke Aline Boer; Hannelouise Kissow; Cathrine Ørskov; Jens J Holst; Bolette Hartmann; Mette M Rosenkilde
Journal:  Br J Pharmacol       Date:  2022-01-11       Impact factor: 9.473

Review 9.  Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors.

Authors:  Jessica Lu; Sarah J Piper; Peishen Zhao; Laurence J Miller; Denise Wootten; Patrick M Sexton
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

10.  Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals.

Authors:  David M Irwin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-12       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.